Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2007. Start Trial.
Date Value
September 30, 2026 2.665M
June 30, 2026 3.034M
March 31, 2026 2.806M
December 31, 2025 2.209M
September 30, 2025 2.638M
June 30, 2025 2.834M
March 31, 2025 3.463M
December 31, 2024 3.695M
September 30, 2024 3.244M
June 30, 2024 3.765M
March 31, 2024 3.182M
December 31, 2023 3.404M
September 30, 2023 3.646M
June 30, 2023 3.732M
March 31, 2023 4.609M
December 31, 2022 5.484M
September 30, 2022 7.17M
June 30, 2022 7.283M
March 31, 2022 7.498M
December 31, 2021 7.517M
September 30, 2021 5.70M
June 30, 2021 5.120M
March 31, 2021 4.371M
December 31, 2020 3.874M
September 30, 2020 4.678M
Date Value
June 30, 2020 5.561M
March 31, 2020 6.457M
December 31, 2019 6.436M
September 30, 2019 5.642M
June 30, 2019 4.327M
March 31, 2019 2.911M
December 31, 2018 2.096M
September 30, 2018 1.694M
June 30, 2018 1.515M
March 31, 2018 1.350M
December 31, 2017 1.043M
September 30, 2017 0.8412M
June 30, 2017 0.5339M
March 31, 2017 0.2965M
December 31, 2016 0.2116M
September 30, 2016 0.2103M
June 30, 2016 0.2853M
March 31, 2016 0.5112M
December 31, 2015 0.8553M
September 30, 2015 0.7974M
June 30, 2015 0.7735M
March 31, 2015 0.5328M
December 31, 2014 0.155M
September 30, 2014 0.1014M
June 30, 2014 0.057M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Liquidia Corp. 70.90M
Johnson & Johnson 16.02B
Eli Lilly & Co. 15.38B
Merck & Co., Inc. 27.55B
ANI Pharmaceuticals, Inc. 50.60M